California State Teachers Retirement System (CalSTRS)’s Monopar Therapeutics MNPR Stock Holding History
Bought
Maintained
Sold
Other funds holding MNPR
RCM
SVCM
DM
SL
ACM
PCH
VCM
California State Teachers Retirement System (CalSTRS)'s MNPR Position: Q1 2026 in Review
California State Teachers Retirement System (CalSTRS) reduced its Monopar Therapeutics (MNPR) stake by 12% in Q1 2026, selling an estimated $2.05K and leaving 247 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2567.
California State Teachers Retirement System (CalSTRS) first reported a position in MNPR in Q2 2025 and has held it in 4 quarters since. The position peaked at $20.8K in Q3 2025. 82 funds tracked by Wall St. Rank hold MNPR as of Q1 2026.
- California State Teachers Retirement System (CalSTRS) held 247 shares of Monopar Therapeutics worth $13.5K as of Q1 2026.
- California State Teachers Retirement System (CalSTRS) sold 34 Monopar Therapeutics shares in Q1 2026, an estimated $2.05K.
- Monopar Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2567 holding.
- California State Teachers Retirement System (CalSTRS) first reported a position in Monopar Therapeutics in Q2 2025 and has held it in 4 quarters since.
- California State Teachers Retirement System (CalSTRS)'s Monopar Therapeutics position peaked at $20.8K in Q3 2025.
- 82 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q1 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.